Axcelis Technologies (NASDAQ:ACLS) Given Buy Rating at B. Riley Financial

Axcelis Technologies (NASDAQ:ACLS)‘s stock had its “buy” rating reaffirmed by B. Riley Financial in a research note issued to investors on Friday, Benzinga reports. They currently have a $140.00 price target on the semiconductor company’s stock, down from their previous price target of $165.00. B. Riley Financial‘s target price would indicate a potential upside of 42.07% from the stock’s previous close.

ACLS has been the topic of a number of other reports. Craig Hallum raised Axcelis Technologies from a “hold” rating to a “buy” rating and set a $140.00 price objective on the stock in a report on Friday. Weiss Ratings raised Axcelis Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, October 16th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $145.33.

Axcelis Technologies Stock Performance

Shares of Axcelis Technologies stock traded up $8.54 on Friday, hitting $98.54. The stock had a trading volume of 69,671 shares, compared to its average volume of 594,227. Axcelis Technologies has a twelve month low of $73.60 and a twelve month high of $193.78. The business’s 50 day moving average is $116.08 and its two-hundred day moving average is $122.65. The company has a quick ratio of 3.21, a current ratio of 4.90 and a debt-to-equity ratio of 0.04. The stock has a market cap of $3.04 billion, a price-to-earnings ratio of 32.72, a price-to-earnings-growth ratio of 2.81 and a beta of 1.88.

Axcelis Technologies (NASDAQ:ACLS) last announced its earnings results on Thursday, November 5th. The semiconductor company reported $1.26 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.15. The company had revenue of $237.78 million for the quarter, compared to analyst estimates of $230.08 million. Axcelis Technologies had a return on equity of 11.69% and a net margin of 10.71%. The firm’s quarterly revenue was up 11.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.21 earnings per share. Axcelis Technologies has set its Q4 2026 guidance at 1.500-1.500 EPS. Analysts forecast that Axcelis Technologies will post 3.39 EPS for the current year.

Institutional Trading of Axcelis Technologies

A number of institutional investors have recently bought and sold shares of ACLS. Wellington Management Group LLP bought a new position in shares of Axcelis Technologies during the second quarter worth approximately $13,070,000. The Manufacturers Life Insurance Company raised its position in shares of Axcelis Technologies by 3,402.5% in the first quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock valued at $45,772,000 after buying an additional 477,705 shares in the last quarter. Reinhart Partners LLC. raised its position in shares of Axcelis Technologies by 14.2% in the third quarter. Reinhart Partners LLC. now owns 1,060,636 shares of the semiconductor company’s stock valued at $139,134,000 after buying an additional 131,976 shares in the last quarter. Entropy Technologies LP acquired a new stake in shares of Axcelis Technologies in the first quarter valued at approximately $1,004,000. Finally, Segall Bryant & Hamill LLC boosted its stake in shares of Axcelis Technologies by 96.1% in the first quarter. Segall Bryant & Hamill LLC now owns 200,371 shares of the semiconductor company’s stock valued at $18,651,000 after buying an additional 98,184 shares during the period. Institutional investors own 89.98% of the company’s stock.

More Axcelis Technologies News

Here are the key news stories impacting Axcelis Technologies this week:

• Positive Sentiment: Q3 results topped expectations. Axcelis reported revenue of $237.8 million, up 11.3% year over year, versus estimates of about $230 million. Non-GAAP diluted EPS was $1.26, above the $1.11 consensus. Axcelis Q3 financial results
• Positive Sentiment: Q4 guidance exceeded consensus. The company forecast revenue of $275 million and EPS of $1.50, compared with analyst estimates of about $239.3 million and $1.18, respectively. Axcelis Q4 outlook and merger timing
• Positive Sentiment: Craig-Hallum upgraded ACLS to Buy from Hold and set a $140 price target, signaling improved analyst sentiment. Craig-Hallum upgrade
• Neutral Sentiment: Axcelis said it is targeting completion of its merger with Veeco by the end of Q1 2027. The deal’s eventual impact will depend on closing and integration. Axcelis Q4 outlook and merger timing

Axcelis Technologies Company Profile

Axcelis Technologies, Inc develops and manufactures equipment used in the fabrication of semiconductor devices. The company is best known for its ion implantation systems, which precisely introduce dopant atoms into silicon wafers to control the electrical properties of semiconductor components.

Its product portfolio includes the Purion family of ion implantation systems, designed for applications such as high-current, medium-current and high-energy implantation. Axcelis also provides related aftermarket products and services, including spare parts, equipment upgrades, process support and customer training.

Headquartered in Beverly, Massachusetts, Axcelis serves semiconductor manufacturers and other customers in major chip-production regions worldwide.